137862-53-4 + 149709-62-6 = 936623-90-4 + 137862-53-4 + 149709-62-6 反应条件:1.1 Reagents: Sodium Hydroxide Solvents: Acetone,Water; 1 H,25 - 35 °C 标题:Preparation Of Solid State Forms Of Trisodium Salt Of Valsartan/sacubitril Complex And Sacubitril Sodium 参考文献:World Intellectual Property Organization]
42882-31-5 + 137862-53-4 + 149709-62-6 = 936623-90-4 + 137862-53-4 + 149709-62-6 反应条件:1.1 Solvents: Acetone; 10 Min,Rt1.2 Reagents: Sodium Hydroxide Solvents: Water; 10 - 20 °C; 1 H,10 - 20 °C 标题:Preparation Of Sacubitril And Salt Thereof And Novel Compounds Used In The Process 参考文献:World Intellectual Property Organization]
391230-93-6 + 149690-05-1 = 936623-90-4 + 137862-53-4 + 149709-62-6 反应条件:1.1 Solvents: Acetone,Water; 10 Min,Rt; 30 Min,Rt -> 80 °C 标题:Novel Crystal Forms Of Entresto: A Supramolecular Complex Of Trisodium Sacubitril/valsartan Hemi-Pentahydrate 作者:Shaikh,Tabrez R.; George,Christy P.; Bhukya,Priyanka; Shelke,Nikita; Pawar,Komal; Et Al 参考文献:Crystengcomm 日期:2022 卷标:24(42) 页码:7387-7393]
137862-53-4 + 149709-62-6 = 936623-90-4 + 137862-53-4 + 149709-62-6 反应条件:1.1 Reagents: Sodium Hydroxide Solvents: Acetone,Water; 1 H,25 - 35 °C 标题:Preparation Of Solid State Forms Of Trisodium Salt Of Valsartan/sacubitril Complex And Sacubitril Sodium 参考文献:World Intellectual Property Organization]
1: Fabris E, Merlo M, Rapezzi C, Ferrari R, Metra M, Frigerio M, Sinagra G. Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach. Drugs. 2019 Sep;79(14):1543-1556. doi: 10.1007/s40265-019-01181-2. Review. doi: 10.4070/kcj.2019.0136. Review. 3: De Vecchis R, Ariano C. Vasodilatory Properties of Sacubitril/Valsartan Explored in Hypertensives Aged Over 55 Years: A Meta-Analysis. High Blood Press Cardiovasc Prev. 2019 Apr 1. doi: 10.1007/s40292-019-00313-9. [Epub ahead of print] Review. Sacubitril/valsartan: A practical guide. Rev Port Cardiol. 2019 May;38(5):309-313. doi: 10.1016/j.repc.2018.10.008. Epub 2019 Jan 22. Review. English, Portuguese. doi: 10.1007/s10741-018-9757-1. Review. 6: Gori M, D'Elia E, Senni M. Sacubitril/valsartan therapeutic strategy in HFpEF: Clinical insights and perspectives. Int J Cardiol. 2019 Apr 15;281:158-165. doi: 10.1016/j.ijcard.2018.06.060. Epub 2018 Nov 9. Review. doi: 10.1007/s40256-018-0306-z. Review. doi: 10.1016/j.hfc.2018.06.012. Epub 2018 Aug 17. Review. doi: 10.1016/j.ihj.2018.01.002. Epub 2018 Jan 8. Review.